image credit: Freepik

Stem cell therapy trial shows promising results for treating progressive MS

November 28, 2023


Results from the trial show potential for developing an advanced cell therapy treatment for the condition.

Affecting around two million people globally, MS is a neurodegenerative condition that affects the brain and spinal cord.

Around two-thirds of people with MS will transition into a debilitating secondary progressive phase of the disease within 25 to 30 years of diagnosis.

In a study published in Cell Stem Cell, scientists successfully injected neural stem cells directly into the brains of 15 patients recruited from two hospitals in Italy, with secondary MS.

Read More on PMLiVE